Plain-English translation of NCT04733729 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large European study collecting information about people with blood cancers who have had COVID-19. Researchers want to understand how common COVID-19 is in this population, how severe it tends to be, and what happens to patients over time. By gathering real-world data from hospitals, they hope to help doctors better protect and care for people living with both conditions.
When this study started, doctors knew very little about how COVID-19 affects people with blood cancers—a group that might be more vulnerable because of their illness and treatment. By collecting information about what actually happened to these patients during the pandemic, researchers can identify patterns and risks that will help guide future medical care.
You likely qualify if…
You likely don't qualify if…
If you qualify, your hospital will review and share your medical records with the study team—no visits or tests are required from you. Researchers will look at information like your demographics, your blood cancer diagnosis and treatment history, how severe your COVID-19 was, and how you recovered over 30 days. All your information will be kept private and entered into a secure database that only your hospital can access.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy